Notificação de entrada na fase nacional - PCT
#1.3
12/23/2025
RPI 2868
Application data
Number
112025010402Type
Filing
Publication
PCT
US2023080649 Examination has not been requested yet. Without that request by 11/21/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:11/21/2026(88 days left)
Latest action published by the INPI: 12/23/2025. We update with every new RPI gazette, published weekly.
Applicants
MEDICON PHARMACEUTICALS, INC.
US
Inventors
B. R. (pessoa física)
US
IPC Classification
Priority claims
US
63/384,790 · 11/23/2022
US
63/384,792 · 11/23/2022
US
63/384,793 · 11/23/2022
US
63/384,794 · 11/23/2022
US
63/384,795 · 11/23/2022
US
63/384,796 · 11/23/2022
US
63/483,353 · 02/06/2023
Abstract
TRATAMENTO DA DOR ASSOCIADA A SENSIBILIZAÇÃO CENTRAL. A invenção apresenta métodos de tratamento da dor, por exemplo, dor associada à sensibilização central, com NSAIDs modificados, por exemplo, fosfosulindaco.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
12/23/2025
RPI 2868
#1.1
06/10/2025
RPI 2840
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.